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Background: Several in vitro studies indicate that activation of airway P2 receptors by extracellular ATP may modulate innate immunity and pathogen-induced inflammatory responses. Clearance of ATP by ectonucleotidases likely plays a central role in the control of inflammation as accelerated ATP metabolism occurs in chronic infectious lung diseases. Our study aimed at investigating the role of mucosal ATP in innate defense against bacterial infection.
Methods: We have generated transgenic mice overexpressing the human ectonucleoside triphosphate diphosphohydrolases CD39 (NTPDase 1) under the control of the airway-specific Clara cell 10-kDa protein gene promoter. 
Results: Immunohistochemistry verified lung-specific overexpression of the transgene. Luciferase assays and reversed-phase HPLC performed on bronchoalveolar lavage (BAL) fluids of transgenic mice indicated increased ectonucleotidase activity as compared to wild-type samples. These mice did not show any spontaneous lung inflammation. However, intratracheal instillation of E. coli lipopolysaccharride (LPS) revealed accelerated recruitment of neutrophils in the airways of transgenic mice whereas macrophage counts remained identical. 
Conclusions: The mCC10-hCD39 transgenic mice develop enhanced airway inflammatory response upon bacterial challenge. They constitute new tools to investigate further the role of mucosal ATP in airway innate immunity as well as to evaluate nucleotide therapeutic potentials in chronic lung infectious diseases.

